Amneal Pharmaceuticals, Inc. - Class A Common Stock (NQ:AMRX)

13.04 +0.09 (+0.66%)

Streaming Delayed Price Updated: 3:33 PM EDT, May 29, 2026 Add to My Watchlist

Price and Volume

Volume	1,082,842
Open	12.97
Bid (Size)	13.03 (900)
Ask (Size)	13.04 (2,000)
Prev. Close	12.95
Today's Range	12.83 - 13.21
52wk Range	7.070 - 15.42
Shares Outstanding	1,000
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Q4 Earnings Highlights: Amneal (NASDAQ:AMRX) Vs The Rest Of The Generic Pharmaceuticals Stocks

May 26, 2026

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ...

Via StockStory

2 Reasons AMRX is Risky and 1 Stock to Buy Instead

May 12, 2026

Amneal trades at $12.64 and has moved in lockstep with the market. Its shares have returned 6.2% over the last six months while the S&P 500 has gained 7.9%. ...

Via StockStory

Performance

YTD	+3.0%	+3.0%
1 Month	+2.4%	+2.4%
3 Month	-10.0%	-10.0%
6 Month	+4.1%	+4.1%
1 Year	+80.8%	+80.8%

More News

Amneal Reports First Quarter 2026 Financial Results

May 07, 2026

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

Amneal (AMRX) Q3 2025 Earnings Call Transcript ↗

May 04, 2026

Via The Motley Fool

Amneal (AMRX) Q2 2025 Earnings Transcript ↗

May 04, 2026

Via The Motley Fool

1 Value Stock to Target This Week and 2 Facing Challenges

May 04, 2026

Via StockStory

Amneal (AMRX) Q1 2026 Earnings Transcript ↗

May 01, 2026

Via The Motley Fool

Amneal (AMRX) Q1 Earnings Report Preview: What To Look For

April 29, 2026

Via StockStory

Kashiv BioSciences Agrees to Be Acquired by Amneal Pharmaceuticals to Create a Fully Integrated Global Biosimilar Leader

April 22, 2026

From Kashiv BioSciences, LLC

Via Business Wire

Amneal Agrees to Acquire Kashiv BioSciences to Create Global Biosimilar Leader; Reports Strong Preliminary First Quarter 2026 Financial Results and Raises FY2026 Standalone Guidance

April 22, 2026

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results with CREXONT® for Parkinson’s Disease, Including Over 3 More Hours of Daily “Good On” Time When Switching from RYTARY®

April 20, 2026

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

Bruker, Amneal, Amphastar Pharmaceuticals, Dentsply Sirona, and PacBio Stocks Trade Up, What You Need To Know

April 17, 2026

Via StockStory

Amneal Launches First Two Respiratory Metered-Dose Inhalation Products in the U.S.

April 14, 2026

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

2 Cash-Producing Stocks to Research Further and 1 We Brush Off

April 13, 2026

Via StockStory

Amneal Launches Bimatoprost Ophthalmic Solution, 0.01%

April 09, 2026

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

3 of Wall Street’s Favorite Stocks We Steer Clear Of

April 08, 2026

Via StockStory

Amneal to Report First Quarter 2026 Results on May 1, 2026

April 07, 2026

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

Amneal Announces $2 Million Donation to Support Patient Access to Essential Medicines During Parkinson’s Awareness Month

April 07, 2026

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

3 Small-Cap Stocks Walking a Fine Line

March 30, 2026

Via StockStory

Q4 Earnings Roundup: Amneal (NASDAQ:AMRX) And The Rest Of The Generic Pharmaceuticals Segment

March 10, 2026

Via StockStory

3 Reasons to Avoid AMRX and 1 Stock to Buy Instead

March 10, 2026

Via StockStory

3 Value Stocks We’re Skeptical Of

March 05, 2026

Via StockStory

Amneal to Participate in Upcoming Investor Conference

March 05, 2026

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

Why Amneal (AMRX) Stock Is Trading Lower Today

February 27, 2026

Via StockStory

Amneal (AMRX) Q4 2025 Earnings Call Transcript ↗

February 27, 2026

Via The Motley Fool

Frequently Asked Questions

Is Amneal Pharmaceuticals, Inc. - Class A Common Stock publicly traded?

Yes, Amneal Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.

What exchange does Amneal Pharmaceuticals, Inc. - Class A Common Stock trade on?

Amneal Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Amneal Pharmaceuticals, Inc. - Class A Common Stock?

The ticker symbol for Amneal Pharmaceuticals, Inc. - Class A Common Stock is AMRX on the Nasdaq Stock Market

What is the current price of Amneal Pharmaceuticals, Inc. - Class A Common Stock?

The current price of Amneal Pharmaceuticals, Inc. - Class A Common Stock is 13.04

When was Amneal Pharmaceuticals, Inc. - Class A Common Stock last traded?

The last trade of Amneal Pharmaceuticals, Inc. - Class A Common Stock was at 05/29/26 03:33 PM ET

What is the market capitalization of Amneal Pharmaceuticals, Inc. - Class A Common Stock?

The market capitalization of Amneal Pharmaceuticals, Inc. - Class A Common Stock is 13.04K

How many shares of Amneal Pharmaceuticals, Inc. - Class A Common Stock are outstanding?

Amneal Pharmaceuticals, Inc. - Class A Common Stock has 13K shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.